Form 4: REVB Director Acquires Shares via Equity Plan
Insider Transaction Report
REVELATION BIOSCIENCES Director Lakhmir S Chawla acquired 15,625 shares of common stock through a restricted stock grant.
Summary
- Lakhmir S Chawla, a Director of REVELATION BIOSCIENCES, INC. (REVB), acquired 15,625 shares of common stock.
- The transaction occurred on October 29, 2025, at a price of $1.28 per share.
- The acquisition was a Restricted Stock Grant under the company's 2021 Equity Incentive Plan.
- These granted shares will vest 100% on January 28, 2026.
- Following this transaction, Lakhmir S Chawla directly beneficially owns a total of 15,686 shares of common stock.
Sentiment
Score: 7
Explanation: The acquisition of shares by a director, even through a restricted stock grant, generally indicates management's confidence in the company's future performance, which is a positive signal for investors.
Positives
- A Director acquiring shares signals confidence in the company's future prospects.
- The grant is part of an equity incentive plan, aligning management's interests with shareholders.
Future Outlook
The restricted stock grant is set to vest 100% on January 28, 2026, indicating a future milestone for the director's equity ownership.
Industry Context
This filing reports an individual insider transaction and does not provide broader industry context or trends.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan Utilization | The transaction was a Restricted Stock Grant under the 2021 Equity Incentive Plan, demonstrating the ongoing use of the plan for executive and director compensation. | 10/29/2025 | Reinforces alignment of director interests with long-term shareholder value through equity-based compensation. |
Stakeholder Impact
- Shareholders may view the director's increased stake as a positive indicator of confidence in the company's future.
Next Steps
- The restricted stock grant will vest 100% on January 28, 2026.
Key Dates
| Date | Description |
|---|---|
| 10/29/2025 | Date of transaction (acquisition of restricted stock grant) |
| 10/30/2025 | Date the Form 4 was filed |
| 01/28/2026 | Date when the restricted stock grant vests 100% |
Recommendation
holdThe acquisition of shares by a director is a positive signal, suggesting confidence in the company's future. However, a single insider transaction, particularly a restricted stock grant, typically does not provide sufficient information to warrant a strong buy or sell recommendation without broader financial and operational context. Investors should hold and monitor further developments.
Keywords
REVELATION BIOSCIENCES, REVB, Lakhmir S Chawla, Form 4, insider trading, stock acquisition, director, restricted stock, equity incentive plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.